Zobrazeno 1 - 10
of 22
pro vyhledávání: '"G B, Mann"'
Autor:
Stephen Della-Fiorentina, Gavin Marx, R De Boer, J. J Rutovitz, Janine M. Lombard, Laura Chin-Lenn, Shane White, T M Hughes, Alexandra Gorelik, Belinda E Kiely, Nicole McCarthy, M F Cronk, D Tsoi, S S Foo, Jacquie Chirgwin, Yoland Antill, Ross Jennens, G B Mann, Eva Segelov
Publikováno v:
Asia-Pacific Journal of Clinical Oncology. 14:410-416
Objectives Industry-supported decision impact studies demonstrate that Oncotype Dx (ODX) changes treatment recommendations (TR) in 24-40% of hormone receptor+/HER2- patients. ODX is not reimbursed by third-party payers in Australia, potentially resul
Autor:
S Della Fiorentina, Nicole McCarthy, R De Boer, J Rutovitz, Daphne Tsoi, Ross R Jennens, Janine M. Lombard, S S Foo, BE Kiely, M F Cronk, Jacquie Chirgwin, L Chin-Lenn, T M Hughes, Yoland Antill, Gavin Marx, G B Mann, Stuart White, A Gorelik, Eva Segelov
Publikováno v:
Cancer Research. 76:P5-15
Background: An Australian industry-funded decision impact study demonstrated that Oncotype Dx (ODX) changed treatment recommendations (TR) in 24% of hormone receptor+/HER2- patients. ODX is available in Australia, but is self-funded by patients (∼U
Autor:
G. B., Mann
Publikováno v:
Breast Cancer Research Review; 2024, Issue 42, p2-2, 1/3p
Autor:
N, Zdenkowski, P, Butow, G B, Mann, S, Fewster, C, Beckmore, R, Isaacs, C, Douglas, F M, Boyle
Publikováno v:
Internal medicine journal. 46(6)
Neoadjuvant systemic therapy (NAST) has become an established treatment option for women with operable breast cancer.We aimed to better understand NAST treatment patterns, barriers and facilitators in Australia and New Zealand.We undertook a cross-se
Publikováno v:
European journal of cancer care. 23(4)
Breast cancer and its treatment have complex ramifications for women of reproductive age, including reduced fertility. With the aim of increasing understanding of what it means to women to manage fertility and motherhood in the years after a diagnosi
Publikováno v:
Japanese Journal of Clinical Oncology. 28:443-449
group) will contribute to different stage-specific results. Other possible explanations for the differences include the therapeutic effect of surgical treatment, with more extensive surgery in Japan. The Dutch trial ofD1 vs D2lymphadenectomyshowed no
Autor:
Patrick I. Borgen, G. B. Mann
Publikováno v:
Journal of Surgical Oncology. 67:267-274
Two genes, called BRCA- I and BRCA-2, have been identified that appear to be responsible for the majority of familial breast cancer syndromes. These genes now play a prominent role in the practice of the surgeon treating breast cancer. Additional gen
Publikováno v:
Reproduction. 99:505-512
In this study a rapid, simple and inexpensive procedure is described which allows potential germ-line male mice to be identified with confidence. Spermatozoa recovered by uterine washing following mating with normal female mice was analysed in two wa
Publikováno v:
British Journal of Cancer
Recent studies involving animal models of cancer and clinicopathological analyses of human tumours suggest that the growth of lymphatic vessels (lymphangiogenesis) in or nearby tumours is associated with the metastatic spread of cancer. The best vali
Publikováno v:
Genomics. 16:782-784
TGF alpha is a mitogenic polypeptide found in the conditioned media of transformed cell lines as well as in various solid tumors. Although its physiological role in normal tissues is uncertain, the autocrine action of TGF alpha on the EGF receptor is